FDA Approved: VARUBI — Supplemental Application (TerSera Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for VARUBI (rolapitant) submitted by TerSera Therapeutics LLC to update the product label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• VARUBI (rolapitant)

Snippet

SUPPL AP for VARUBI (ROLAPITANT)